Roberta Ragazzini

Roberta Ragazzini

Auto-generated profile, based on publicly available information

Roberta Ragazzini

Epithelial Stem Cell Biology and Regenerative Medicine Laboratory, The Francis Crick Institute, London, UK

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2021 in Nature
Verified
Journal Article
Open access
PDF file
LTLucy G. Thorne
Lucy G. Thorne
MBMehdi Bouhaddou
Mehdi Bouhaddou
ARAnn-Kathrin Reuschl
Ann-Kathrin Reuschl
LZLorena Zuliani-Alvarez
Lorena Zuliani-Alvarez
BPBen Polacco
Ben Polacco
NKNevan J. Krogan
Nevan J. Krogan
The emergence of SARS-CoV-2 variants of concern suggests viral adaptation to enhance human-to-human transmission1,2. Although much effort has focused on the characterization of changes in the spike protein in variants of concern, mutations outside of spike are likely to contribute to adaptation. Here, using unbiased abundance proteomics, phosphoproteomics, RNA sequencing and viral replication assays, we show that isolates of the Alpha (B.1.1.7) variant3suppress innate immune responses in airway epithelial cells more effectively than first-wave isolates. We found that the Alpha variant has markedly increased subgenomic RNA and protein levels of the nucleocapsid protein (N), Orf9b and Orf6—all known innate immune antagonists. Expression of Orf9b alone suppressed the innate immune response through interaction with TOM70, a mitochondrial protein that is required for activation of the RNA-sensing adaptor MAVS. Moreover, the activity of Orf9b and its association with TOM70 was regulated by phosphorylation. We propose that more effective innate immune suppression, through enhanced expression of specific viral antagonist proteins, increases the likelihood of successful transmission of the Alpha variant, and may increase in vivo replication and duration of infection4. The importance of mutations outside the spike coding region in the adaptation of SARS-CoV-2 to humans is underscored by the observation that similar mutations exist in the N and Orf9b regulatory regions of the Delta and Omicron variants.

6 February 2017 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
MPManuela Portoso
Manuela Portoso
RRRoberta Ragazzini
Roberta Ragazzini
ŽBŽiva Brenčič
Živa Brenčič
AMArianna Moiani
Arianna Moiani
AMAudrey Michaud
Audrey Michaud
RMRaphaël Margueron
Raphaël Margueron
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

26 August 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
RRRoberta Ragazzini
Roberta Ragazzini
RPRaquel Pérez-Palacios
Raquel Pérez-Palacios
IBIrem H. Baymaz
Irem H. Baymaz
SDSeynabou Diop
Seynabou Diop
KAKatia Ancelin
Katia Ancelin
RMRaphaël Margueron
Raphaël Margueron
The Polycomb group of proteins is required for the proper orchestration of gene expression due to its role in maintaining transcriptional silencing. It is composed of several chromatin modifying complexes, including Polycomb Repressive Complex 2 (PRC2), which deposits H3K27me2/3. Here, we report the identification of a cofactor of PRC2, EZHIP (EZH1/2 Inhibitory Protein), expressed predominantly in the gonads. EZHIP limits the enzymatic activity of PRC2 and lessens the interaction between the core complex and its accessory subunits, but does not interfere with PRC2 recruitment to chromatin. Deletion of Ezhip in mice leads to a global increase in H3K27me2/3 deposition both during spermatogenesis and at late stages of oocyte maturation. This does not affect the initial number of follicles but is associated with a reduction of follicles in aging. Our results suggest that mature oocytes Ezhip−/− might not be fully functional and indicate that fertility is strongly impaired in Ezhip−/− females. Altogether, our study uncovers EZHIP as a regulator of chromatin landscape in gametes.

11 December 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
Sara CampinotiSara Campinoti
Sara Campinoti
AGAsllan Gjinovci
Asllan Gjinovci
RRRoberta Ragazzini
Roberta Ragazzini
LZLuca Zanieri
Luca Zanieri
LALinda Ariza-McNaughton
Linda Ariza-McNaughton
PBPaola Bonfanti
Paola Bonfanti
The thymus is a primary lymphoid organ, essential for T cell maturation and selection. There has been long-standing interest in processes underpinning thymus generation and the potential to manipulate it clinically, because alterations of thymus development or function can result in severe immunodeficiency and autoimmunity. Here, we identify epithelial-mesenchymal hybrid cells, capable of long-term expansion in vitro, and able to reconstitute an anatomic phenocopy of the native thymus, when combined with thymic interstitial cells and a natural decellularised extracellular matrix (ECM) obtained by whole thymus perfusion. This anatomical human thymus reconstruction is functional, as judged by its capacity to support mature T cell development in vivo after transplantation into humanised immunodeficient mice. These findings establish a basis for dissecting the cellular and molecular crosstalk between stroma, ECM and thymocytes, and offer practical prospects for treating congenital and acquired immunological diseases.

16 January 2024 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
ARAnn-Kathrin Reuschl
Ann-Kathrin Reuschl
LTLucy G. Thorne
Lucy G. Thorne
MWMatthew V. X. Whelan
Matthew V. X. Whelan
RRRoberta Ragazzini
Roberta Ragazzini
WFWilhelm Furnon
Wilhelm Furnon
GTGreg J. Towers
Greg J. Towers
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) human adaptation resulted in distinct lineages with enhanced transmissibility called variants of concern (VOCs). Omicron is the first VOC to evolve distinct globally dominant subvariants. Here we compared their replication in human cell lines and primary airway cultures and measured host responses to infection. We discovered that subvariants BA.4 and BA.5 have improved their suppression of innate immunity when compared with earlier subvariants BA.1 and BA.2. Similarly, more recent subvariants (BA.2.75 and XBB lineages) also triggered reduced innate immune activation. This correlated with increased expression of viral innate antagonists Orf6 and nucleocapsid, reminiscent of VOCs Alpha to Delta. Increased Orf6 levels suppressed host innate responses to infection by decreasing IRF3 and STAT1 signalling measured by transcription factor phosphorylation and nuclear translocation. Our data suggest that convergent evolution of enhanced innate immune antagonist expression is a common pathway of human adaptation and link Omicron subvariant dominance to improved innate immune evasion.

24 January 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
DMDejan Mesner
Dejan Mesner
ARAnn-Kathrin Reuschl
Ann-Kathrin Reuschl
MWMatthew V. X. Whelan
Matthew V. X. Whelan
TBTaylor Bronzovich
Taylor Bronzovich
THTafhima Haider
Tafhima Haider
CJClare Jolly
Clare Jolly
SARS-CoV-2 spike requires proteolytic processing for viral entry. A polybasic furin-cleavage site (FCS) in spike, and evolution toward an optimized FCS by dominant variants of concern (VOCs), are linked to enhanced infectivity and transmission. Here we show interferon-inducible restriction factors Guanylate-binding proteins (GBP) 2 and 5 interfere with furin-mediated spike cleavage and inhibit the infectivity of early-lineage isolates Wuhan-Hu-1 and VIC. By contrast, VOCs Alpha and Delta escape restriction by GBP2/5 that we map to the spike substitution D614G present in these VOCs. Despite inhibition of spike cleavage, these viruses remained sensitive to plasma membrane IFITM1, but not endosomal IFITM2 and 3, consistent with a preference for TMPRSS2-dependent plasma membrane entry. Strikingly, we find that Omicron is unique among VOCs, being sensitive to restriction factors GBP2/5, and also IFITM1, 2, and 3. Using chimeric spike mutants, we map the Omicron phenotype and show that the S1 domain determines Omicron’s sensitivity to GBP2/5, whereas the S2’ domain determines its sensitivity to endosomal IFITM2/3 and preferential use of TMPRSS2-independent entry. We propose that evolution of SARS-CoV-2 for the D614G substitution has allowed for escape from GBP restriction factors, but the selective pressures on Omicron for spike changes that mediate antibody escape, and altered tropism, have come at the expense of increased sensitivity to innate immune restriction factors that target virus entry.